Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Immune Reconstitution

Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen

Bone Marrow Transplantation volume 28, pages 243–249 (2001)Cite this article

Abstract

We have investigated the immune status of patients with hematologic malignancies treated with a low intensity conditioning in preparation for allogeneic stem cell transplantation. Conditioning consisted of fludarabine, anti-T lymphocyte globulin and low-dose busulfan, followed by infusion of allogeneic blood stem cells. This protocol resulted in rapid engraftment and complete replacement of host with donor hematopoietic cells. Immunological parameters of these patients were compared to those patients who were conditioned by an aggressive myeloablative regimen. Distribution of cell surface markers of lymphocyte subsets from both groups of patients was similar, but different from that of normal control cells. Reduced intensity or non-myeloablative conditioning prior to allogeneic stem cell transplantation (NST), hardly lowered the normal T cell-dependent mitogenic response even during the early period following transplant, while the myeloablative treatments resulted in a suppressed mitogenic reaction and in slow immune recovery. Reactivity of non-MHC restricted cytotoxic T cells was also at a normal level in patients who were treated with NST. We conclude that stem cell engraftment following reduced conditioning may result in early reconstitution of immune responses assessed in vitro. We hypothesize that clinical application of NST may lead to faster development of effective immune responses against residual host-type malignant and abnormal non-malignant hematopoietic cells, although the role of fludarabine on post-transplant infections remains to be investigated in a larger cohort of patients. Bone Marrow Transplantation (2001) 28, 243–249.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Thomas ED . Kettering Award lecture. The role of marrow transplantation in the eradication of malignant disease Cancer 1982 49: 1963–1969

    Article  CAS  PubMed  Google Scholar 

  2. O'Reilly RJ . Allogeneic bone marrow transplantation: current status and future directions Blood 1983 62: 941–964

    CAS  PubMed  Google Scholar 

  3. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation Blood 1990 75: 555–562

    CAS  PubMed  Google Scholar 

  4. Lucarelli G, Galimberti M, Polci P et al. Bone marrow transplantation in patients with thalassemia New Engl J Med 1990 322: 417–421

    Article  CAS  PubMed  Google Scholar 

  5. Symann M, Bosly A, Gisselbrecht C et al. Immune reconstitution after bone marrow transplantation Cancer Treat Rev 1989 16: (Suppl. A) 15–19

    Article  PubMed  Google Scholar 

  6. Moller J, Hofmann B, Jacobsen N et al. Defective T-cell stimulatory pathways in patients after allogeneic bone marrow transplantation (BMT) in man APMIS 1993 101: 480–486

    Article  CAS  PubMed  Google Scholar 

  7. Kameoka J, Sato T, Torimoto Y et al. Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation Blood 1995 85: 1132–1137

    CAS  PubMed  Google Scholar 

  8. Pignata C, Sanghera JS, Soiffer RJ et al. Defective activation of mitogen-activated protein kinase after allogeneic bone marrow transplantation Blood 1996 88: 2334–2341

    CAS  PubMed  Google Scholar 

  9. Witherspoon RP, Kopecky K, Storb RF et al. Immunological recovery in 48 patients following syngeneic marrow transplantation for hematological malignancy Transplantation 1982 33: 143–149

    Article  CAS  PubMed  Google Scholar 

  10. Witherspoon RP, Lum LG, Storb R . Immunologic reconstitution after human marrow grafting Semin Hematol 1984 21: 2–10

    CAS  PubMed  Google Scholar 

  11. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756–763

    CAS  PubMed  Google Scholar 

  12. Keating MJ, Kantarjian H, Talpaz M et al. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia Blood 1989 74: 19–25

    CAS  PubMed  Google Scholar 

  13. Johnson S, Smith AG, Loffler H et al. Multicentre prospective randomized trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL Lancet 1996 347: 1432–1438

    Article  CAS  PubMed  Google Scholar 

  14. Rohatiner A, Lister TA . Management of follicular lymphoma Curr Opin Oncol 1994 6: 473–479

    Article  CAS  PubMed  Google Scholar 

  15. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 1997 89: 4531–4536

    CAS  PubMed  Google Scholar 

  16. Boyum A . Isolation of leukocytes from human blood Scand J Clin Lab Invest 1968 21: (Suppl. 97) 77–89

    Article  CAS  Google Scholar 

  17. Morecki S, Nabet C, Ackerstein A et al. The effect of in vitro T lymphocyte depletion on generation of IL2-activated cytotoxic cells Bone Marrow Transplant 1991 7: 269–273

    CAS  PubMed  Google Scholar 

  18. Petrie A . Linear regression and correlation In: Lecture Notes on Medical Statistics Blackwell: London 1978 pp 102–128

    Google Scholar 

  19. Morecki S, Revel-Vilk S, Nabet C et al. Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-α2a and interleukin-2 Cancer Immunol Immunother 1992 35: 401–411

    Article  CAS  PubMed  Google Scholar 

  20. Shiobara S, Ueda M, Harada M et al. Long-term observation of immunologic reconstitution after allogeneic bone marrow transplantation: differences in recovery among functional T cell subsets Nippon-Ketsueki-Gakkai-Zasshi 1989 52: 55–62

    CAS  PubMed  Google Scholar 

  21. Soiffer RJ, Bosserman L, Murray C et al. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation Blood 1990 75: 2076–2084

    CAS  PubMed  Google Scholar 

  22. Parra C, Roldan E, Rodriguez C et al. Immunologic reconstitution of peripheral blood lymphocytes in patients treated by bone marrow transplantation Med Clin Barc 1996 106: 169–173

    CAS  PubMed  Google Scholar 

  23. Bengtsson M, Smedmyr B, Festin R et al. B lymphocyte regeneration in marrow and blood after autologous bone marrow transplantation: increased numbers of B cells carrying activation and progression markers Leukemia Res 1989 13: 791–797

    Article  CAS  Google Scholar 

  24. Kelsey SM, Lowdell MW, Newland AC . IgG subclass levels and immune reconstitution after T cell-depleted allogeneic bone marrow transplantation Clin Exp Immunol 1990 80: 409–412

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Leino L, Lilius EM, Nikoskelainen J et al. The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic bone marrow transplantation Bone Marrow Transplant 1991 8: 339–344

    CAS  PubMed  Google Scholar 

  26. Foot AB, Potter MN, Donaldson C et al. Immune reconstitution after BMT in children Bone Marrow Transplant 1993 11: 7–13

    CAS  PubMed  Google Scholar 

  27. Lowdell MW, Craston R, Ray N et al. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia Bone Marrow Transplant 1998 21: 679–686

    Article  CAS  PubMed  Google Scholar 

  28. Chan EY, Chiu EK, So MK et al. Peripheral blood lymphocyte subsets after allogeneic bone marrow transplantation: reconstitution and correlation with the occurrence of acute graft-versus-host disease Asian Pac J Allergy Immunol 1994 12: 117–123

    CAS  PubMed  Google Scholar 

  29. Lange A, Jazwiec B, Tomaszewska-Toporska B, Toporski J . Recovery of natural cytotoxicity after bone marrow transplantation Immunol Invest 1991 20: 207–213

    Article  CAS  PubMed  Google Scholar 

  30. Comoli P, Maccario R, Montagna D et al. Expression of p75 chain of IL-2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantation Clin Exp Immunol 1994 97: 510–516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Murphy WJ, Longo DL . The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation Immunol Rev 1997 157: 167–176

    Article  CAS  PubMed  Google Scholar 

  32. Velardi A, Terenzi A, Cucciaioni S et al. Imbalances within the peripheral blood T-helper (CD4+) and T-suppressor (CD8+) cell populations in the reconstitution phase after human bone marrow transplantation Blood 1988 71: 1196–1200

    CAS  PubMed  Google Scholar 

  33. Lum LG, Joshi ID, Smith MR et al. Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact Bone Marrow Transplant 1994 13: 187–195

    CAS  PubMed  Google Scholar 

  34. Slavin S, Strober S, Fuks Z, Kaplan HS . Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation Science 1976 193: 1252–1254

    Article  CAS  PubMed  Google Scholar 

  35. Slavin S, Strober S, Fuks Z, Kaplan HS . Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice. Long-term survival of allogeneic bone marrow and skin grafts J Exp Med 1977 146: 34–48

    Article  CAS  PubMed  Google Scholar 

  36. Slavin S, Reitz B, Bieber CP et al. Transplantation tolerance in adult rats using total lymphoid irradiation (TLI): permanent survival of skin, heart and marrow allografts J Exp Med 1978 147: 700–707

    Article  CAS  PubMed  Google Scholar 

  37. Slavin S, Fuks Z, Strober S et al. Overview: transplantation tolerance across major histocompatibility barriers after total lymphoid irradiation Transplantation 1979 28: 359–361

    Article  CAS  PubMed  Google Scholar 

  38. Slavin S . Total lymphoid irradiation (TLI) Immunol Today 1987 8: 88–92

    Article  CAS  PubMed  Google Scholar 

  39. Prigozhina T, Gurevitch O, Zhu J, Slavin S . Permanent and specific transplantation tolerance induced by a non-myeloablative treatment to a wide variety of allogeneic tissues Transplantation 1997 63: 1394–1399

    Article  CAS  PubMed  Google Scholar 

  40. Ildstad ST, Sachs DH . Reconstitution with syngeneic plus allogeneic or xenogeneic bone marow leads to specific acceptance of allografts and xenografts Nature 1984 307: 168–170

    Article  CAS  PubMed  Google Scholar 

  41. Sharabi Y, Sachs DH . Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen J Exp Med 1989 169: 493–502

    Article  CAS  PubMed  Google Scholar 

  42. Sykes M, Szot GL, Swenson KA, Pearson DA . Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning Nat Med 1997 3: 783–787

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was carried out in the Danny Cunniff Leukemia Research Laboratory. We wish to thank the Gabrielle Rich Leukemia Research Foundation; Baxter International Corporation; the German–Israel Foundation; the Cancer Treatment Foundation; the Szydlowsky Foundation; and Pauline and Jerry Silverstein for their continuous support of our ongoing basic and clinical research in cell therapy.

Author information

Authors and Affiliations

  1. Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital, Jerusalem, Israel

    S Morecki, Y Gelfand, A Nagler, R Or, E Naparstek, G Varadi, D Engelhard, A Akerstein & S Slavin

Authors
  1. S Morecki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Gelfand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Nagler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Or
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Naparstek
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G Varadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D Engelhard
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Akerstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Slavin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morecki, S., Gelfand, Y., Nagler, A. et al. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen. Bone Marrow Transplant 28, 243–249 (2001). https://doi.org/10.1038/sj.bmt.1703118

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703118

Keywords

This article is cited by

Search

Advanced search

Quick links